VAST THERAPEUTICS, INC.
Biotech · Private
Inhaled nitric oxide-releasing prodrug formulation (ALX1) for treating bacterial lung infections
- Grants
- $3.0M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Nebulized ALX1 as a treatment for Pseudomonas aeruginosa infections in bronchiectasis patients | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Nebulized ALX1 as a Treatment for Difficult Non-tuberculous Mycobacterial Lung Infections | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Nebulized ALX1 as a treatment for Pseudomonas aeruginosa infections in bronchiectasis patients | $988,594 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1968 | Mersana Therapeutics | — | $69M |
| 1969 | F-STOP, LLC | — | $85K |
| 1970 | CMP TARNHELM PARTNERS, LLC | — | — |
| 1971 | VAST THERAPEUTICS, INC. | — | — |
| 1972 | Vesicor Therapeutics, Inc. | — | $715K |
| 1973 | FasCure Therapeutics LLC | — | — |
| 1974 | UBIQUITX, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.